How one health system is using radiation to treat heart patients who ’ve run out of options
Ventricular tachycardia (VT) is a common, potentially life-threatening heart arrhythmia that occurs in the organ ’s lower chambers in patients with heart disease or heart failure, which can lead to sudden cardiac death. While there are a variety of treatments, not all of them work for people suffering from the disorder. One of the most common treatments, a cardiac catheter ablation, can fail nearly half of the time in preventing further episodes of VT. Medication is another option, but sometimes… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 12, 2021 Category: Biotechnology Authors: Laura Newpoff Source Type: news

Texas Woman Sentenced to 6 Months in Federal Prison for Selling Deadly Weight Loss Drug to Consumers
FDA OCI, Judith Holloway, Watauga TX, DNP, 2,4-Dinitrophenol, weight loss, cataracts, dangerous, side effects, hyperthermia, tachycardia, cardiac arrhythmia, death, misbranded, yellow pigment powder, bulk purchase, eBay, hazardous, false label, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 7, 2021 Category: Medical Law Authors: DOJ Source Type: news

Apple study finds Watch can detect more types of irregular heartbeats
The most common arrhythmias detected were premature atrial contractions, premature ventricular contractions, atrial tachycardia and nonsustained ventricular tachycardia. (Source: mobihealthnews)
Source: mobihealthnews - September 29, 2021 Category: Information Technology Source Type: news

ECG Challenge: What Caused This Man's Atrial Arrhythmia? ECG Challenge: What Caused This Man's Atrial Arrhythmia?
A 77-year-old hypertensive man has atrial fibrillation, but his ECG patterns reveal more about the arrythmia.Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 27, 2021 Category: Cardiology Tags: Cardiology Clinical Case Source Type: news

Marijuana Use Disorder and Arrhythmias: What Were They Smoking? Marijuana Use Disorder and Arrhythmias: What Were They Smoking?
The authors of this editorial poke several holes in a new study which purports to assess the association of arrhythmias with cannabis use disorder in teenagers.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Heart rhythm disorders: Mayo Clinic Healthcare expert shares 5 things it's important to know
World Heart Day is Sept. 29 LONDON — Heart rhythm disorders are one of the most common cardiac problems. Arrhythmias cause the heart to beat too fast, too slow, or irregularly. People can be born with them or develop them during their lives. Elijah Behr, M.D., a cardiologist at Mayo Clinic Healthcare in London, shares five developm ents in the prevention, detection and treatment of arrhythmias. What cardiologists now know about arrhythmias and COVID-19:  “We know… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 21, 2021 Category: Databases & Libraries Source Type: news

A Good Night's Sleep Linked to Lower Arrhythmia Risk A Good Night's Sleep Linked to Lower Arrhythmia Risk
In a study of more than 400,000 people, those who reported generally sleeping through the night had less atrial fibrillation and bradyarrhythmia than those who reported having difficulty sleeping.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 14, 2021 Category: Internal Medicine Tags: Cardiology News Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Classification of Apparent Idiopathic Ventricular Fibrillation Classification of Apparent Idiopathic Ventricular Fibrillation
A new study outlines a previously undefined subtype of idiopathic ventricular fibrillation, described as a distinct primary arrhythmia syndrome: short-coupled ventricular fibrillation.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dapagliflozin in HFrEF May Cut Arrhythmias, Sudden Death: DAPA-HF Dapagliflozin in HFrEF May Cut Arrhythmias, Sudden Death: DAPA-HF
Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies among key subgroups.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 27, 2021 Category: Neurology Tags: Cardiology News Source Type: news

ICMs Detect Serious Arrhythmias in High-Risk Post-MI: SMART-MI ICMs Detect Serious Arrhythmias in High-Risk Post-MI: SMART-MI
After an MI, implantable cardiac monitors are sensitive for detecting serious arrhythmias in patients with cardiac autonomic dysfunction but only moderately reduced LVEF, according to new trial results.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 27, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news

Aerobic Exercise Can Reduce AF Frequency, Severity: ACTIVE-AF Aerobic Exercise Can Reduce AF Frequency, Severity: ACTIVE-AF
The ACTIVE-AF trial demonstrates that some patients can control their arrhythmia through physical activity, without the need for ablation or medications, researchers conclude.Medscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - August 26, 2021 Category: Universities & Medical Training Tags: Cardiology News Source Type: news

High vagal tone and rapid extinction learning as potential transdiagnostic protective factors following childhood violence exposure - Susman ES, Weissman DG, Sheridan MA, McLaughlin KA.
Childhood exposure to violence is strongly associated with psychopathology. High resting respiratory sinus arrhythmia (RSA) is associated with lower levels of psychopathology in children exposed to violence. High RSA may help to protect against psychopatho... (Source: SafetyLit)
Source: SafetyLit - August 25, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Genetic sequencing uncovers new possible links to cardiac rhythm disorder
The findings of the Yale School of Medicine-led study are a major step in uncovering the genetic causes of a poorly understood type of heart arrhythmia. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 27, 2021 Category: Universities & Medical Training Source Type: news

Landmark study finds one in two hospitalised COVID-19 patients develop a complication, NIHR
A large-scale, NIHR-supported observational study published in The Lancet has found that one in two people hospitalised with COVID-19 during the first phase of the pandemic developed at least one health complication as a result of the viral infection. The ISARIC/CO-CIN study is the most comprehensive of its kind - and the first to systematically assess a range of in-hospital complications and their associations with age, sex and ethnicity - and their outcomes for the patients. The researchers assessed more than 70,000 hospitalised adult patients in the UK hospitalised with severe COVID-19 disease between January and Augu...
Source: Current Awareness Service for Health (CASH) - July 26, 2021 Category: Consumer Health News Source Type: news

Interactive effects of childhood maltreatment and tonic respiratory sinus arrhythmia on young adults' depressive symptoms - Zhang H, Luo Y, Davis T, Zhang L.
The goal of the current study was to investigate the moderating effect of tonic respiratory sinus arrhythmia (RSA) in the relation between childhood maltreatment and depression symptoms among young adults. A total of 98 participants (70 women) aged 17-22  ... (Source: SafetyLit)
Source: SafetyLit - July 23, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Coffee doesn't raise your risk for heart rhythm problems
(University of California - San Francisco) In the largest study of its kind, an investigation by UC San Francisco has found no evidence that moderate coffee consumption can cause cardiac arrhythmia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 20, 2021 Category: International Medicine & Public Health Source Type: news

Coffee Won't Upset Your Heartbeat. It Might Even Calm It
A large new study has found that most people can enjoy their coffee or diet cola free from heart worries -- caffeine doesn't seem to increase most people's risk of arrhythmias. (Source: WebMD Health)
Source: WebMD Health - July 19, 2021 Category: Consumer Health News Source Type: news

Greater Daily Coffee Intake May Lower Risk for Arrhythmia
MONDAY, July 19, 2021 -- Higher amounts of habitual coffee intake are associated with a reduced risk for arrhythmia, according to a study published online July 19 in JAMA Internal Medicine. Eun-jeong Kim, M.D., from the University of California in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2021 Category: Pharmaceuticals Source Type: news

Coffee Not Linked to Increased Arrhythmia Risk in New Study Coffee Not Linked to Increased Arrhythmia Risk in New Study
Habitual coffee drinking was not associated with a heightened risk for cardiac arrhythmias in a study of more than 300,000 people.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2021 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Health: Drinking coffee can REDUCE your risk of heart arrhythmias, study finds
The impact of coffee consumption on arrhythmia incidence was analysed among more than 380,000 people by researchers led from the University of California, San Francisco. (Source: the Mail online | Health)
Source: the Mail online | Health - July 19, 2021 Category: Consumer Health News Source Type: news

Predictive factors for recurrence of serious arrhythmias in patients with acute digoxin poisoning - El-Sarnagawy GN, El Sharkawy SI, Helal NE.
Although digoxin poisoning has declined in the past decades, it still has deleterious outcomes. The hallmark of serious life-threatening arrhythmias remains challenging due to its non-specific initial presentation. Therefore, this study aimed to evaluate t... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

More Evidence Epilepsy Tied to Risk for Major CV Events More Evidence Epilepsy Tied to Risk for Major CV Events
Patients with epilepsy are at greater risk for major cardiovascular events, including stroke and clinically significant arrhythmia, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 7, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Traumatic injury and atrial fibrillation among deployed service members - Alcover KC, Ambardar SR, Poltavskiy E, Nasir JM, Janak JC, Howard JT, Walker LE, Haigney MC, Stewart IJ.
In this study, we investigated the impact of traumatic injury on AF/AFL among service members with deployment ... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

First case of acute poisoning with amiodarone and flecainide in attempted suicide successfully managed with lipid emulsion therapy in the emergency department: case report and literature review - Bologa C, Lionte C, Popescu A, Sorodoc V, Sorodoc L.
We report a 47-year-old patient admitted to the ED 5 h after... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults Polymyositis-Dermatomyositis Tied to Arrhythmias in Young, Middle-Aged Adults
Young and middle-aged adults with polymyositis-dermatomyositis are more likely to have arrhythmias than matched controls without these rare rheumatic conditions, a US study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2021 Category: Consumer Health News Tags: Rheumatology News Source Type: news

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duratio...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

High voltage electrical injuries: outcomes & 1-year follow-up from a level 1 trauma centre - Goyal D, Jagne N, Dhiman A, Patil V, Rattan A.
BACKGROUND: High voltage (>1000 V) electric injuries (HVEI) are rare, and dreaded due to profound myonecrosis and fatal arrhythmias. Trauma Centres are well equipped for acute and definitive treatment of injuries. Paucity of burn centres in Himalayan belt ... (Source: SafetyLit)
Source: SafetyLit - June 9, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Space travel weakens our immune systems: Now scientists may know why
(University of California - San Francisco) Microgravity in space perturbs human physiology and is detrimental for astronaut health, a fact first realized during early Apollo missions when astronauts experienced inner ear disturbances, heart arrhythmia, low blood pressure, dehydration, and loss of calcium from their bones after their missions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

What Are Some Indications for Using Dexamethasone?
Discussion Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Childhood abuse and social anxiety symptoms among young adults: moderating role of respiratory sinus arrhythmia suppression to social stress - Ji H, Lu W.
BACKGROUND: Childhood abuse (CA) has been considered as an environmental risk factor for the development of social anxiety symptoms. Respiratory sinus arrhythmia (RSA) is a biomarker that has been found to interact with environmental stressors to affect ps... (Source: SafetyLit)
Source: SafetyLit - May 24, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

IMBRUVICA ® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukemia Demonstrates High Rates of Disease Control
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the fixed-duration cohort of the investigational Phase 2 CAPTIVATE study, showing that 95 percent of patients treated with combined IMBRUVICA® plus venetoclax were alive and progression-free at two years.[1] Deep remissions were seen across all subgroups, including patients with high-risk chronic lymphocytic leukemia (CLL).1 In addition, long-term data from the RESONATE-2 (PCYC-1115/1116) study will be presented, providing the longest follow-up Phase 3 data for any BTK inhibitor to date. Thes...
Source: Johnson and Johnson - May 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Compound may prevent risk of a form of arrhythmia from common medications
(Washington University in St. Louis) The team discovered a compound that prevents and even reverses the underlying physiological change that can lead some drugs to cause heart problems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2021 Category: International Medicine & Public Health Source Type: news

Death Risk Up for Hospitalized Cannabis Users With Arrhythmias
THURSDAY, May 13, 2021 -- Hospitalized patients who use cannabis and have an arrhythmia have worse outcome than cannabis users without arrhythmias, according to a study presented at EHRA 2021, an online scientific congress hosted by the European... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Greater effectiveness in the treatment of arrhythmia with radio frequency energy and catheterization
(Universitat Pompeu Fabra - Barcelona) An article published in International Journal of Hyperthermia proposes a more effective protocol for the treatment of cardiac arrhythmias when applying radiofrequency energy at the site of the arrhythmia by catheterization. The research results from the final year project on the bachelor's degree in Biomedical Engineering by Sergi Coderch Navarro, supervised by Ana Gonz á lez Su á rez and Oscar Camara, researchers with the PhySense group of the BCN MedTech Research Unit. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 6, 2021 Category: International Medicine & Public Health Source Type: news

UBCO cardiovascular researcher urges women to listen to their hearts
(University of British Columbia Okanagan campus) Dr. Ryan Wilson, a post-doctoral fellow in the School of Nursing, says AF is the most commonly diagnosed arrhythmia (irregular heartbeat) in the world. Despite that, he says many people do not understand the pre-diagnosis symptoms and tend to ignore them. In fact, 77 per cent of the women in his most recent study had experienced symptoms for more than a year before receiving a diagnosis. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 5, 2021 Category: International Medicine & Public Health Source Type: news

Coffee Intake May Be Driven by Cardiovascular Symptoms Coffee Intake May Be Driven by Cardiovascular Symptoms
Observational results show those with hypertension, angina, or arrhythmia drink less coffee than those without. That behavior may explain mixed results in studies of coffee's effects.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 3, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Scientists created technology to detect and treat complex arrhythmias
(Ural Federal University) Researchers have developed a breakthrough method for quickly, accurately, and reliably diagnosing cardiac arrhythmias. It coped with the task in 38 cases out of 51. In other words, it is highly effective in almost 75% of cases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news

Study: Pot users with arrhythmias face greater risk of death
Hospitalized marijuana users with irregular heartbeats are 4 1/2 times more likely to die than those with normal heart rates, research presented Friday during the Congress of the European Society of Cardiology showed. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 23, 2021 Category: Consumer Health News Source Type: news

Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); ho...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
Amber Capone had become afraid of her husband. The “laid-back, bigger than life and cooler than cool” man she’d married had become isolated, disconnected and despondent during his 13 years as a U.S. Navy SEAL. Typically, he was gone 300 days of the year, but when he was home, Amber and their two children walked on eggshells around him. “Everyone was just playing nice until he left again,” Amber says. In 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent dreams worse. Sometimes he’d get up...
Source: TIME: Health - April 5, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Drugs feature Magazine Mental Health Source Type: news

Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who are taking the seizure and mental health medicine lamotrigine (Lamictal). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ultrasound spots cardiac arrhythmic sites better than ECG
Ultrasound can more accurately map arrhythmic sites in the heart for improve...Read more on AuntMinnie.comRelated Reading: ASTRO: Radiation therapy can calm rapid heart rhythm 3D models advance therapy for heart rhythm disorders SPECT, MRI together advance arrhythmia treatment 3D virtual heart helps pinpoint irregular heartbeat CTA plus stress tests help predict heart attacks (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2021 Category: Radiology Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships - Gr émain V, Chevillard L, Saussereau E, Schnell G, Megarbane B.
BACKGROUND: Caffeine poisoning may cause life-threatening arrhythmias and hemodynamic failure. We aimed to investigate the toxicokinetics (TK), toxicodynamics (TD) and TK/TD relationships of caffeine in a case of poisoning. CASE REPORT: A 47-year-old male ... (Source: SafetyLit)
Source: SafetyLit - March 17, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

The Year in Cardiovascular Medicine 2020: Arrhythmias The Year in Cardiovascular Medicine 2020: Arrhythmias
This paper reviews new guidelines and important clinical trials and studies that were published in 2020 in the field of arrhythmias and pacing.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

What Are Generalized Anxiety Disorder Treatment Components?
Discussion Generalized anxiety disorder (GAD) is “…excessive anxiety and worry about a number of events and activities coupled with at least one physical symptom, which may include fatigue, poor concentration, restlessness, irritability, muscle tension, and sleep difficulties.” Other ways it presents to the primary care office may be abdominal pain, headache or heart palpitations, dizziness, syncope, numbness, trembling, paresthesia, memory loss, or urinary frequency. It has an estimated prevalence of 15% and is the second most common anxiety disorder in children after social anxiety disorder. GAD can co...
Source: PediatricEducation.org - March 15, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

New-onset Arrhythmias Low in COVID-19 and Flu New-onset Arrhythmias Low in COVID-19 and Flu
New-onset atrial fibrillation or flutter is uncommon in patients hospitalized with COVID-19 and occurs at a rate similar to that seen in patients hospitalized with influenza.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 5, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

New open-source platform accelerates research into the treatment of heart arrhythmia's
(King's College London) An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering& Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterised by an irregular (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 26, 2021 Category: International Medicine & Public Health Source Type: news